

Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|9|10|801-809
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.9, Iss.10, 2003-04, pp. : 801-809
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content






By Oztas B.
Pharmacological Research, Vol. 37, Iss. 3, 1998-03 ,pp. :


Insulin and the Blood-Brain Barrier
Current Pharmaceutical Design, Vol. 9, Iss. 10, 2003-04 ,pp. :


Blood-Brain Barrier P-Glycoprotein Function in Neurodegenerative Disease
Current Pharmaceutical Design, Vol. 17, Iss. 26, 2011-09 ,pp. :